Dermatology
Letters to Dermatology
Unsuccessful Association of Zidovudine and Interferon Alpha for Acute Adult T-Cell Leukemia LymphomaDega H.a · Chosidow O.a · Charlotte F.b · Francès C.a · Herson S.a · Leblond V.cDepartment of aInternal Medicine, bPathology and cHematology, Groupe Hospitalier Pitié-Salpêtrière, Université Paris-6, Paris, France
|
|
Dermatology 1999;198:103–105
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
Published online: February 18, 1999
Issue release date: 1999
Number of Print Pages: 3
Number of Figures: 2
Number of Tables: 0
ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)
For additional information: https://www.karger.com/DRM
First-Page Preview
Related Articles:
References
-
Shimoyama M: Treatment of patients with adult T-cell leukemia-lymphoma: An overview. Gann Monogr Cancer Res 1992;39:43–56.
- Gill PS, Harrington W Jr, Kaplan MH, et al: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995;332:1744–1748.
- Hermine O, Bouscary D, Gessain A, et al: Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995;332:1749–1751.
- Shimoyama M, and members of the Lymphoma Study Group: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Haematol 1991;79:428–437.
-
Tobinai K, Kobayashi Y: Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma. N Engl J Med 1995;333:1285.
External Resources
Article / Publication Details
Published online: February 18, 1999
Issue release date: 1999
Number of Print Pages: 3
Number of Figures: 2
Number of Tables: 0
ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)
For additional information: https://www.karger.com/DRM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
